Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The leishmanolysin-like pseudogene (ENSG00000224245, LOC100421692) is a human genome locus predicted to have sequence similarity to leishmanolysin proteins of the metallopeptidase M8 family, but it does not encode a functional protein due to disabling mutations and is classified as a pseudogene[4][5][6]. Human pseudogenes, including this locus, typically result from ancestral duplication or retrotransposition events, followed by degradation via frameshifts or premature stop codons that abolish protein-coding capacity[1][2][6]. Pseudogenes such as this may retain some sequence similarity to coding genes but are generally considered nonfunctional, not acting as receptors, enzymes, or drug targets. There is no evidence for involvement in any regulatory role, disease association, or pharmacological activity, nor is it a biomarker for clinical use[4][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Leishmanolysin-like pseudogene.